These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21838876)

  • 21. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer.
    Fiore LS; Ganguly SS; Sledziona J; Cibull ML; Wang C; Richards DL; Neltner JM; Beach C; McCorkle JR; Kaetzel DM; Plattner R
    Oncogene; 2014 Sep; 33(36):4508-4520. PubMed ID: 24096484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
    Guo HB; Liu F; Zhao JH; Chen HL
    J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lentivirus-mediated stable silencing of nm23-H1 gene in lung cancer cells and the influence on biological behavior].
    Luo M; Zhu D; Gong L; Qiu X; Zu L; Sun L; Wu Z; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2012 Mar; 15(3):139-45. PubMed ID: 22429576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue.
    Andolfo I; De Martino D; Liguori L; Petrosino G; Troncone G; Tata N; Galasso A; Roma C; Chiancone F; Zarrilli S; Arrigoni G; Staibano S; Imbimbo C; Zollo M
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):489-98. PubMed ID: 21553004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated extracellular vesicular Nm23-H1 subdues the pro-migratory potential of breast cancer cell-derived extracellular vesicles.
    Saini V; Do Y; Yam JWP; Wong YH
    Cell Signal; 2024 Aug; 120():111203. PubMed ID: 38723736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recruited metastasis suppressor NM23-H2 attenuates expression and activity of peroxisome proliferator-activated receptor δ (PPARδ) in human cholangiocarcinoma.
    He F; York JP; Burroughs SG; Qin L; Xia J; Chen D; Quigley EM; Webb P; LeSage GD; Xia X
    Dig Liver Dis; 2015 Jan; 47(1):62-7. PubMed ID: 25277864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
    Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
    Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethanol inhibits B16-BL6 melanoma metastasis and cell phenotypes associated with metastasis.
    Kushiro K; Núñez NP
    In Vivo; 2012; 26(1):47-58. PubMed ID: 22210715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
    Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
    Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest.
    Howlett AR; Petersen OW; Steeg PS; Bissell MJ
    J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1.
    Khera L; Paul C; Kaul R
    Virology; 2017 Jun; 506():110-120. PubMed ID: 28376369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ITGA5 Promotes Tumor Progression through the Activation of the FAK/AKT Signaling Pathway in Human Gastric Cancer.
    Wang JF; Chen YY; Zhang SW; Zhao K; Qiu Y; Wang Y; Wang JC; Yu Z; Li BP; Wang Z; Chen JQ
    Oxid Med Cell Longev; 2022; 2022():8611306. PubMed ID: 36193075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma.
    Liu SJ; Sun YM; Tian DF; He YC; Zeng L; He Y; Ling CQ; Sun SH
    Br J Cancer; 2008 Jan; 98(2):363-9. PubMed ID: 18219290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
    BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
    Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
    Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small molecule activator of Nm23/NDPK as an inhibitor of metastasis.
    Lee JJ; Kim HS; Lee JS; Park J; Shin SC; Song S; Lee E; Choi JE; Suh JW; Lee H; Kim EE; Seo EK; Shin DH; Lee HY; Lee HY; Lee KJ
    Sci Rep; 2018 Jul; 8(1):10909. PubMed ID: 30026594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethanol enhances erbB-mediated migration of human breast cancer cells in culture.
    Luo J; Miller MW
    Breast Cancer Res Treat; 2000 Sep; 63(1):61-9. PubMed ID: 11079160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations at the dimer interface and surface residues of Nm23-H1 metastasis suppressor affect its expression and function.
    Li Y; Liu W; Saini V; Wong YH
    Mol Cell Biochem; 2020 Nov; 474(1-2):95-112. PubMed ID: 32705629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.
    Pantano F; Croset M; Driouch K; Bednarz-Knoll N; Iuliani M; Ribelli G; Bonnelye E; Wikman H; Geraci S; Bonin F; Simonetti S; Vincenzi B; Hong SS; Sousa S; Pantel K; Tonini G; Santini D; Clézardin P
    Oncogene; 2021 Feb; 40(7):1284-1299. PubMed ID: 33420367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.